Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics - Concepedia

Concepedia

Publication | Closed Access

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

85

Citations

29

References

2011

Year

Esther H. Lips, Lennart Mulder, Jorma J. de Ronde, Ingrid A.M. Mandjes, Andrew Vincent, Marie-Jeanne T. F. D. Vrancken Peeters, Petra M. Nederlof, Jelle Wesseling, Sjoerd Rodenhuis

Breast Cancer Research and Treatment

Breast OncologyMedicineImmunologyPathologyResponse PredictionImmune Checkpoint InhibitorMolecular CharacteristicsBreast CancerCancer TreatmentOncologyTumor MicroenvironmentEndocrine-related CancerNeoadjuvant Chemotherapy

References

	Year	Citations

Page 1

Page 1